Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renuva for Glottal Insufficiency
NCT04700566Phase 3Unknown
- Sponsor
- University of Southern California
- Start
- May 2022
- Primary completion
- Dec 2024
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Renuva Allograft Adipose Matrix in vocal fold insufficiency, sponsored by University of Southern California. Status: unknown.
02
Drugs
Renuva Allograft Adipose Matrix
03
Conditions
vocal fold insufficiency
Beyond the preview
Go deeper on NCT04700566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700566.